Cargando…
Next‐generation bromodomain inhibitors of the SWI/SNF complex enhance DNA damage and cell death in glioblastoma
Glioblastoma (GBM) is an aggressive brain cancer with a poor prognosis. While surgical resection is the primary treatment, adjuvant temozolomide (TMZ) chemotherapy and radiotherapy only provide slight improvement in disease course and outcome. Unfortunately, most treated patients experience recurren...
Autores principales: | Yang, Chuanhe, He, Yali, Wang, Yinan, McKinnon, Peter J., Shahani, Vijay, Miller, Duane D., Pfeffer, Lawrence M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494295/ https://www.ncbi.nlm.nih.gov/pubmed/37593885 http://dx.doi.org/10.1111/jcmm.17907 |
Ejemplares similares
-
Targeting the Bromodomain of BRG-1/BRM Subunit of the SWI/SNF Complex Increases the Anticancer Activity of Temozolomide in Glioblastoma
por: Yang, Chuanhe, et al.
Publicado: (2021) -
Swi/Snf dynamics on stress-responsive genes is governed by competitive bromodomain interactions
por: Dutta, Arnob, et al.
Publicado: (2014) -
The Bromodomains of the mammalian SWI/SNF (mSWI/SNF) ATPases Brahma (BRM) and Brahma Related Gene 1 (BRG1) promote chromatin interaction and are critical for skeletal muscle differentiation
por: Sharma, Tapan, et al.
Publicado: (2021) -
SWI/SNF Infobase—An exclusive information portal for SWI/SNF remodeling complex subunits
por: Mani, Udayakumar, et al.
Publicado: (2017) -
A new, highly conserved domain in Swi2/Snf2 is required for SWI/SNF remodeling
por: Sen, Payel, et al.
Publicado: (2011)